Colesevelam Hcl
Brand names: Colesevelam Hcl, Welchol
At a glance
- Medicare prescriptions, 2024
- 124,928
- Medicare drug cost
- $18.7M
- Average cost per prescription
- $150
- Clinicians who prescribed it
- 6,071
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Colesevelam hydrochloride is a bile acid sequestrant indicated as an adjunct to diet and exercise to: • reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. • reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH), unable to reach LDL-C target levels despite an adequate trial of diet and lifestyle modification. • improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: • Do not use for treatment of type 1 diabetes or for diabetic ketoacidosis. • Not studied in Fredrickson Type I, III, IV, and V dyslipidemias
From the FDA-approved prescribing information (label dated June 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 26.7%
- Internal Medicine 25.5%
- Gastroenterology 18.5%
- Nurse Practitioners 14.7%
- Physician Assistants 5.0%
- Cardiology 2.3%
- Endocrinology & Diabetes 1.5%
- Geriatric Medicine 1.3%
- General Practice 0.9%
- Interventional Cardiology 0.4%
- Hospitalist 0.4%
- General Surgery 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 27% from 2019 to 2024.
Biggest change by state since 2019
- Alabama −4%
- Georgia −14%
- Maryland −16%
- Indiana −17%
- Texas −21%
- North Carolina (smallest change) −40%
- New York (smallest change) −38%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 5 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
A-S Medication Solutions
| Strength | Looks like | Imprint |
|---|---|---|
| 625 mg | yellow oval tablet, 19 mm | C625 |
Ascend Laboratories, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 625 mg | yellow oval tablet, 19 mm | C625 |
Bryant Ranch Prepack
| Strength | Looks like | Imprint |
|---|---|---|
| 625 mg | yellow oval tablet, 19 mm | C625 |
Cosette Pharmaceuticals, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 625 mg | white oval tablet, 19 mm | SANKYO C01 |
Pd-Rx Pharmaceuticals, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 625 mg | yellow oval tablet, 19 mm | C625 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Mar 2025 · Glenmark Pharmaceuticals Inc., USA · Class II
CGMP Deviations
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.